N@N

Matthew Taylor Maintained (ZBH) at Strong Buy with Increased Target to $165 on, Nov 6th, 2019

Matthew Taylor of UBS, Maintained "Zimmer Biomet Holdings, Inc." (ZBH) at Strong Buy with Increased Target from $158 to $165 on, Nov 6th, 2019.

Matthew has made no other calls on ZBH in the last 4 months.

There are 8 other peers that have a rating on ZBH. Out of the 8 peers that are also analyzing ZBH, 1 agrees with Matthew's Rating of Hold. Following is the relevant analyst calls for the last 4 months

---

• Travis Steed of "Barclays" Upgraded from Sell to Hold and Increased Target to $140 on, Tuesday, July 30th, 2019

These are the ratings of the 7 analyists that currently disagree with Matthew

---

• Ryan Zimmerman of "BTIG" Upgraded from Hold to Strong Buy and Held Target at $158 on, Monday, October 7th, 2019
• Kyle Rose of "Canaccord Genuity" Upgraded from Hold to Strong Buy and Increased Target to $167 on, Wednesday, September 18th, 2019
• Larry Biegelsen of "Wells Fargo" Maintained at Buy with Increased Target to $158 on, Monday, September 9th, 2019
• David Toung of "Argus Research" Upgraded from Hold to Strong Buy on, Monday, August 12th, 2019
• Joanne Wuensch of "Citigroup" Maintained at Strong Buy with Increased Target to $158 on, Friday, August 2nd, 2019
• David Lewis of "Morgan Stanley" Maintained at Buy with Increased Target to $150 on, Monday, July 29th, 2019
• Jeff Johnson of "Baird" Upgraded from Hold to Buy and Increased Target to $154 on, Monday, July 29th, 2019

Contributing Sources

---